John L Wade, MD | |
688 Kinoole St Ste 103, Hilo, HI 96720-3868 | |
(808) 969-8010 | |
(903) 663-7394 |
Full Name | John L Wade |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 34 Years |
Location | 688 Kinoole St Ste 103, Hilo, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326087487 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
Scottsdale Thompson Peak Medical Center | Scottsdale, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sonoran Radiology Ltd | 3375964505 | 367 |
Southwest Diagnostic Imaging Ltd | 7416946199 | 87 |
News Archive
Scientists at Korea's Daegu Gyeongbuk Institute of Science and Technology scientists have compiled a comprehensive new public database of genetic information to enable the detection and identification of RNA viruses using the polymerase chain reaction assay.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Ozarks Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
A clinical study on patients who have suffered a heart attack found that a partially purified extract of Chinese red yeast rice, Xuezhikang (XZK), reduced the risk of repeat heart attacks by 45%, revascularization (bypass surgery/angioplasty), cardiovascular mortality and total mortality by one-third and cancer mortality by two-thirds.
› Verified 9 days ago
Entity Name | Southwest Diagnostic Imaging Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902896236 PECOS PAC ID: 7416946199 Enrollment ID: O20040507001294 |
News Archive
Scientists at Korea's Daegu Gyeongbuk Institute of Science and Technology scientists have compiled a comprehensive new public database of genetic information to enable the detection and identification of RNA viruses using the polymerase chain reaction assay.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Ozarks Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
A clinical study on patients who have suffered a heart attack found that a partially purified extract of Chinese red yeast rice, Xuezhikang (XZK), reduced the risk of repeat heart attacks by 45%, revascularization (bypass surgery/angioplasty), cardiovascular mortality and total mortality by one-third and cancer mortality by two-thirds.
› Verified 9 days ago
Entity Name | Sonoran Radiology Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200526002412 |
News Archive
Scientists at Korea's Daegu Gyeongbuk Institute of Science and Technology scientists have compiled a comprehensive new public database of genetic information to enable the detection and identification of RNA viruses using the polymerase chain reaction assay.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Ozarks Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
A clinical study on patients who have suffered a heart attack found that a partially purified extract of Chinese red yeast rice, Xuezhikang (XZK), reduced the risk of repeat heart attacks by 45%, revascularization (bypass surgery/angioplasty), cardiovascular mortality and total mortality by one-third and cancer mortality by two-thirds.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
John L Wade, MD 100 Hospital Dr, Bennington, VT 05201-5004 Ph: () - | John L Wade, MD 688 Kinoole St Ste 103, Hilo, HI 96720-3868 Ph: (808) 969-8010 |
News Archive
Scientists at Korea's Daegu Gyeongbuk Institute of Science and Technology scientists have compiled a comprehensive new public database of genetic information to enable the detection and identification of RNA viruses using the polymerase chain reaction assay.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Ozarks Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
A clinical study on patients who have suffered a heart attack found that a partially purified extract of Chinese red yeast rice, Xuezhikang (XZK), reduced the risk of repeat heart attacks by 45%, revascularization (bypass surgery/angioplasty), cardiovascular mortality and total mortality by one-third and cancer mortality by two-thirds.
› Verified 9 days ago
Manfred Tejerina, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 688 Kinoole St Ste 103, Hilo, HI 96720 Phone: 808-969-8010 Fax: 903-663-7394 | |
Douglas Mitchell Sides, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 688 Kinoole St, Suite 103, Hilo, HI 96720 Phone: 808-935-1825 Fax: 903-663-7394 | |
Dr. Michael Jt Seu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 670 Ponahawai St, #110, Hilo, HI 96720 Phone: 808-933-2540 Fax: 808-935-5207 | |
Dr. David W Camacho, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 670 Ponahawai St, #103, Hilo, HI 96720 Phone: 808-933-2540 Fax: 808-935-5207 | |
Dr. Ming Y Peng, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1190 Waianuenue St, Hilo Medical Center, Hilo, HI 96720 Phone: 808-974-6841 Fax: 808-935-1889 | |
Dr. Scott R Grosskreutz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 82 Puuhonu Pl, #102, Hilo, HI 96720 Phone: 808-961-4746 Fax: 808-933-2532 |